| HOME >> BIOLOGY >> TECHNOLOGY |
+1-916-858-5100
THERMOGENESIS CORP.
Condensed Balance Sheets
Unaudited
June 30, June 30,
2007 2006
ASSETS
Current assets:
Cash and cash equivalents $5,730,000 $3,527,000
Short-term investments 27,649,000 35,472,000
Accounts receivable, net 3,226,000 3,773,000
Inventories, net 5,046,000 2,792,000
Other current assets 415,000 462,000
Total current assets 42,066,000 46,026,000
Equipment, net 1,602,000 1,489,000
Other assets 122,000 88,000
$43,790,000 $47,603,000
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $2,074,000 $1,931,000
Other current liabilities 2,233,000 1,753,000
Total current liabilities 4,307,000 3,684,000
Long-term liabilities 1,671,000 1,947,000
Stockholders' equity 37,812,000 41,972,000
$43,790,000 $47,603,000
THERMOGENESIS CORP.
Condensed Statements of Operations
Unaudited
Three Months Ended Years Ended
June 30, June 30,
2007
'/>"/>
| SOURCE ThermoGenesis Corp. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Metavante Corp. will continue M&A activity
2. Lucigen Corp. enters global licensing agreement
3. CIO Leadership Series: Jane Durment, Marcus Corp.
4. Brady Corp. acquires Korean counterpart
5. Brady Corp. raises $137 million in public offering
6. Symphony Corp. and CareEvolution to partner
7. RedPrairie Corp. introduces new supply chain software
8. California investors acquire RedPrairie Corp.
9. Symphony Corp. moving into Fitchburg Technology Campus
10. Local group building Dane County economic development corp.
11. M & Is Metavante completes Brasfield Corp. acquisition
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |